Sri Lanka drug law reform 2026 has entered a potentially important phase after the Cabinet approved revisions to two connected statutes: the National Dangerous Drugs Control Board Act, No. 11 of 1984, and the Drug Dependent Persons (Treatment and Rehabilitation) Act, No. 54 of 2007.
The decisions, taken at the Cabinet meeting of 20 July 2026, followed proposals submitted by Minister of Public Security and Parliamentary Affairs Ananda Wijepala. The Legal Draftsman has been instructed to prepare amendment bills. This is policy approval to begin drafting; it does not mean that new powers or treatment procedures are already in force.
Considering the laws together is the correct starting point. One establishes the institution responsible for drug-control policy, coordination, research, prevention and rehabilitation. The other regulates treatment centres and voluntary or compulsory admission. Reforming only one could expand institutional authority without improving care, or increase treatment obligations without the coordination needed to deliver them.
Sri Lanka Drug Law Reform 2026: What Cabinet Approved
The Cabinet said the 1984 Act requires revision to expand the role and powers of the National Dangerous Drugs Control Board in response to changing drug misuse. The decision on the 2007 Act referred to a more formal treatment and rehabilitation mechanism, including the government’s intention to identify people using drugs for the first time and reduce the number who develop dependence.
The Cabinet paper does not publish the proposed clauses. It is therefore too early to claim that the amendments will create particular investigative powers, admission procedures or safeguards. Those questions must be assessed when the bills are published.
This distinction is important. Broad objectives such as controlling trafficking, preventing dependence and expanding rehabilitation may attract general support, but the wording of individual provisions will determine whether the resulting system is effective, proportionate and practically enforceable.
Also in Explained | Bridging the Gap: Strengthening Sri Lanka’s Law Enforcement for a Safer Future
The Existing Laws Already Connect Justice and Treatment
The NDDCB’s present role is wider than enforcement. Its statutory functions include national policy formulation, inter-agency coordination, treatment and rehabilitation, preventive education, research and cooperation with national and international organisations.
The 2007 Act provides for designated and licensed private centres, inspections, assessment panels, voluntary admission and court-ordered compulsory admission. Under the compulsory pathway, police may refer a person believed to be drug dependent for examination by a government medical officer before the person is produced before a Magistrate.
Sri Lanka’s 2022 amendments to the Poisons, Opium and Dangerous Drugs Ordinance also created a limited diversion route. In specified circumstances involving less than one gramme, a person seeking treatment may avoid prosecution with the Attorney-General’s sanction, following medical assessment and referral to residential or non-residential treatment. Failure to complete treatment can reactivate prosecution.
The 2026 reforms should therefore not introduce another disconnected process. They should clarify how police referral, medical assessment, prosecutorial discretion, courts, NDDCB services, private facilities and the Bureau of Rehabilitation operate as one national system.
Arrest Data Shows Scale, Not Prevalence
The NDDCB reported 262,321 drug-related arrests in 2025. Methamphetamine accounted for 35.3 per cent, heroin for 31 per cent and cannabis for 29 per cent. From January to May 2026, 121,266 arrests were recorded, with methamphetamine again representing the largest category at 39 per cent.
These are enforcement statistics, not a national prevalence survey. Arrest totals can be influenced by policing intensity, targeted operations, charging practices, geographic priorities and repeated contact with the criminal justice system. They do not establish that everyone arrested has drug dependence or requires residential rehabilitation.
The legal system must distinguish use or possession, clinically assessed dependence, small-scale supply and organised trafficking. Treating these circumstances as one category can overwhelm courts and treatment facilities while diverting enforcement resources from commercial trafficking networks.
Stronger action against organised supply can therefore coexist with proportionate treatment and diversion mechanisms for individuals experiencing drug-use disorders. These are not contradictory policy positions.
First-Time Use Is Not Drug Dependence
The Cabinet decision specifically refers to people using drugs for the first time. Early intervention is reasonable, particularly as synthetic drugs have become more prominent in arrest data. However, first-time or experimental use is not itself a clinical diagnosis of dependence.
An amended law should require structured screening before directing a person into treatment. Some people may need a brief intervention, family support, mental-health assessment or outpatient follow-up. Others may have severe dependence, withdrawal risks or co-occurring psychiatric conditions requiring specialist or residential care.
Automatically institutionalising every first-time user would consume limited beds, increase stigma and potentially place low-risk individuals in inappropriate environments. Ignoring early use would also miss an opportunity to prevent escalation.
The appropriate response is a graduated pathway based on clinical need, personal circumstances and risk, not a single mandatory programme triggered solely by arrest.
Capacity Must Be Matched by Treatment Quality
Sri Lanka recorded 6,030 treatment admissions for drug-use disorders in 2025. Private facilities accounted for 41.8 per cent, NDDCB outreach services for 23.4 per cent, the Bureau of Rehabilitation for 21.5 per cent and NDDCB treatment centres for 12.6 per cent. More than three-quarters of admissions involved residential or institutional care.
In April 2026, the Cabinet approved six short-term treatment and rehabilitation centres for people voluntarily seeking assistance after existing capacity was considered insufficient.
Expansion is necessary, but bed numbers alone do not demonstrate successful rehabilitation. Treatment should follow internationally recognised standards covering clinical assessment, qualified multidisciplinary staff, confidentiality, continuity of care and interventions matched to individual needs.
The large role played by private facilities makes licensing and inspection particularly important. Standards should cover staff qualifications, medical services, medication management, nutrition, family contact, complaints, protection from violence, record-keeping and emergency referrals.
Licensing status and inspection outcomes should be publicly available without revealing patient identities. Serious or repeated violations should result in corrective orders, suspension or closure rather than remaining internal administrative matters.
Stronger NDDCB Powers Should Improve Governance
Expanding the Board’s powers should not be understood only as increasing control over individuals. The more valuable powers may be institutional: requiring standardised data sharing, operating an early-warning system for emerging substances, accrediting programmes, inspecting centres, coordinating district services and publishing measurable outcomes.
Data quality requires attention. In the 2025 treatment dataset, the primary drug was not recorded in 39.9 per cent of admissions, while district information was missing from 27.3 per cent. These gaps weaken geographic planning, service allocation and evaluation.
A stronger NDDCB should be measured by the quality of national coordination, evidence and service standards, not merely by the breadth of its formal authority.
Because the Board participates in policy, research, regulation and treatment provision, the amendments should also address potential overlaps between its provider and regulator functions. An independently reporting inspection or quality-assurance mechanism could strengthen confidence in public, designated and private centres.
A protected national case-management system could follow referrals from initial assessment through treatment and aftercare. Anonymised public reporting could then show where demand exists, which services are working and where people are being lost between institutions.
Also in Explained | Anti-Drug Campaign: Will Sri Lanka’s New Narcotics Restrictions Deliver Real Social Change?
Compulsory Treatment Needs Legal and Clinical Safeguards
The 2007 Act permits compulsory admission and allows courts to determine treatment periods. Reform should define when compulsion is justified, who may assess dependence, how long an order may continue and how continued detention can be reviewed.
Safeguards should include independent clinical assessment, written reasons, access to legal advice, periodic judicial review, a right to challenge continued detention, confidential complaint channels and external inspection. Treatment records should remain protected, and disciplinary force should never become a substitute for clinical care.
International treatment standards favour voluntary, evidence-informed and rights-based services. International organisations have also warned against compulsory detention systems operating without adequate healthcare, consent protections or independent review.
Sri Lanka can retain narrowly defined legal pathways for serious situations while ensuring that rehabilitation does not become punishment under another name.
Rehabilitation Must Continue After Discharge
The Cabinet decision refers to rehabilitation, resocialisation and post-treatment protection. This matters because completing a residential programme is only one stage of recovery.
People leaving treatment may return to unemployment, debt, unstable housing, family conflict or environments where drugs remain readily available. Unless these conditions are addressed, the legal system may repeatedly process the same individuals without producing sustainable recovery.
Every discharge plan should therefore cover continuing healthcare, psychological support, family counselling, peer assistance, vocational training, employment services and relapse-response arrangements. Community health services and trained outreach teams should follow progress at defined intervals.
Programme performance should be assessed through retention in care, physical and mental health, housing stability, employment, family functioning and reduced harmful use, not only the number of admissions or programme completions.
A Unified Reform Framework
The two amendment bills should operate as parts of one national framework.
First, establish clear legal pathways. Organised trafficking requires focused enforcement; clinically assessed drug-use disorders require treatment; first-time or lower-risk use requires screening and proportionate early intervention.
Second, place health expertise inside the decision-making process. Public security, health, justice, social services and education institutions need clearly defined statutory responsibilities.
Third, create a continuum of care. Community and outpatient services should be the accessible first level, with residential care reserved for individuals who clinically require it.
Fourth, regulate every treatment provider against the same standards. Public, private and designated centres should face comparable licensing, inspection, safeguarding and reporting requirements.
Fifth, protect dignity and due process. Compulsory measures should be exceptional, clinically justified, time-limited and independently reviewable.
Finally, publish results. Parliament and the public should receive annual information on referrals, assessments, admissions, waiting periods, complaints, programme completion, follow-up and longer-term outcomes.
Reform Should Reduce Harm, Not Only Increase Control
Cabinet approval creates an opportunity to modernise laws introduced in 1984 and 2007 for a drug environment now shaped by synthetic substances, changing distribution networks and rising demand for treatment.
Success will not be determined by how many additional powers are written into law. It will depend on whether Sri Lanka can identify risk earlier, distinguish users from traffickers, make treatment accessible, regulate centres consistently, protect individual rights and support recovery after discharge.
Enforcement and rehabilitation are not competing strategies. They become effective only when each is directed towards the problem it is designed to solve.
The draft bills should be published for consultation with health professionals, treatment providers, law-enforcement agencies, judges, social workers, people with lived experience and affected families. Scrutiny at the drafting stage can prevent legal authority from expanding faster than treatment quality and institutional accountability.
This analysis is for educational and public-affairs purposes only. It is based on official information available as of 29 July 2026 and does not constitute legal, medical or policy advice.
